# Endo Igf1 Atypical With Comorbidities

> This skill suggests measuring serum IGF-1 in patients who lack typical acromegaly features but present with associated comorbidities such as sleep apnea, type 2 diabetes, debilitating arthritis, carpal tunnel syndrome, hyperhidrosis, or hypertension. It is triggered when a clinician encounters a patient with these conditions without classic signs of acromegaly.

- Skill: `dromlakhani/endo-igf1-atypical-with-comorbidities` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/endo-igf1-atypical-with-comorbidities`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/endo-igf1-atypical-with-comorbidities/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/endo-igf1-atypical-with-comorbidities

---


# Measure IGF-1 in atypical presentation with comorbidities

## STEP 1 — Gather Information
Collect history for the presence of sleep apnea syndrome, type 2 diabetes mellitus, debilitating arthritis, carpal tunnel syndrome, hyperhidrosis, and hypertension; simultaneously assess for typical acromegaly features (acral enlargement, coarse facial features, prognathism) to confirm their absence.

## STEP 2 — Rule In / Rule Out
If the patient has two or more of the listed comorbidities AND lacks typical acromegaly features, proceed to measure IGF-1; otherwise, do not measure IGF-1 and consider alternative explanations for the comorbidities.

## STEP 3 — Classify or Stratify
Interpret the IGF-1 result using age‑adjusted normal ranges for the specific assay: an elevated IGF-1 suggests possible acromegaly, while a normal IGF-1 makes acromegaly unlikely.

## STEP 4 — Decide
If IGF-1 is elevated, proceed to confirm diagnosis with an oral glucose tolerance test (GH suppression) and pituitary MRI; if IGF-1 is normal, pursue other etiologies for the comorbidities and reconsider acromegaly only if new typical features emerge.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely on random GH alone for diagnosis; IGF-1 assays show inter‑laboratory variability, so use the same assay consistently; avoid IGF-1 testing in pregnancy, renal or hepatic failure, or malnutrition without adjusting for known confounders; normal IGF-1 does not exclude acromegaly if assay is inappropriate or if there is assay interference.

## Concrete Clinical Example
A 48‑year‑old woman presents with newly diagnosed hypertension, type 2 diabetes, and bilateral carpal tunnel syndrome; she notes no change in ring or shoe size and her facial appearance is unchanged. IGF-1 is measured and found elevated above the age‑adjusted norm. An oral glucose tolerance test shows failure to suppress GH below 1 µg/L, and a pituitary MRI reveals a 12 mm macroadenoma, leading to a diagnosis of acromegaly.

**Source:** Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700